SCHEMBL6630552

SCHEMBL6630552

COc1cc(OC)cc(-c2ncc[nH]2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 1/20 0.62
NISCH Q9Y2I1 2/20 0.48
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2D6 P10635 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
KDM4E B2RXH2 3/20 0.47
CYP19A1 P11511 1/20 0.47
MTOR P42345 1/20 0.47
ADK P55263 1/20 0.47
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP1A1 P04798 4/20 0.46
CYP1B1 Q16678 4/20 0.46
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2097610 0.82 DYRK1A (0.57) SMPD3NISCHALDH1A1CYP1A2CYP3A4
SCHEMBL771769 0.81 CYP1A2 (0.65) SMPD3NISCHALDH1A1CYP1A2CYP3A4
Bromide SCHEMBL28346147 0.79 CYP1A2 (0.63) SMPD3NISCHALDH1A1CYP1A2CYP3A4
SCHEMBL24575653 0.79 SMPD3 (0.47) SMPD3NISCHALDH1A1CYP1A2CYP3A4
SCHEMBL28494454 0.79 NISCH (0.62) SMPD3NISCHALDH1A1CYP1A2CYP3A4
SCHEMBL771235 0.78 SMPD3 (0.73) SMPD3NISCHALDH1A1KDM4EMTOR
SCHEMBL6002867 0.77 SMPD3 (0.45) SMPD3NISCHALDH1A1CYP1A2CYP3A4
SCHEMBL8727409 0.77 SMPD3 (1.00) SMPD3NISCHALDH1A1KDM4E
SCHEMBL29160554 0.75 CYP1A2 (0.58) SMPD3NISCHALDH1A1CYP1A2CYP3A4
Oxalic Acid SCHEMBL31679093 0.75 PIN1 (0.52) SMPD3NISCHALDH1A1KDM4EMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106699771-A Cryptotanshinone compound, as well as preparation method and application thereof 常州大学 2017-05-24 CN disclosed
CN-103889964-A Tumor targeting drug Combretastatin A4 derivative NANJING SANHOME PHARMACEUTICAL CO LTD 2014-06-25 CN disclosed
WO-2013004075-A1 TUMOR TARGETED DRUG COMBRETASTATIN A4 DERIVATIVE 南京圣和药业有限公司 (CN) 2013-01-10 WO disclosed
EP-1463735-A1 IMIDAZO[2,1-B]-1,3,4-THIADIAZOLE SULFONAMIDES Aegera Therapeutics Inc. (CA) 2004-10-06 EP disclosed
WO-2003051890-A1 IMIDAZO [2,1-B]-1,3,4-THIADIAZOLE SUFLONAMIDES AEGERA THERAPEUTICS INC. (CA) 2003-06-26 WO disclosed